Samsung Biologics to help Enzolytics advance clinical development of mAbs

Samsung Biologics to help Enzolytics advance clinical development of mAbs

Submitted by admin on October 11, 2021 - 10:13am
Source: 
Biopharma Reporter
News Tags: 
Samsung BioLogics
Enzolytics
CDMOs
monoclonal antibodies
Headline: 
Samsung Biologics to help Enzolytics advance clinical development of mAbs
snippet: 

Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production.

Do Not Allow Advertisers to Use My Personal information